Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026)
Steris' (STE) quarterly Non-Current Deferred Tax Liability came in at $390.7 million in Q1 2026, down 3.22% year-on-year from $403.7 million in Q1 2025, and down 5.74% quarter-over-quarter from $414.5 million in Q4 2025.
Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends
Steris' Non-Current Deferred Tax Liability history runs 9 years deep, the most recent figure standing at $390.7 million for Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 3.22% year-over-year to $390.7 million in Q1 2026; TTM through Mar 2026 was $390.7 million, a 3.22% decrease from a year earlier, with the FY2026 full-year figure at $390.7 million, down 3.22% from the prior year.
- Non-Current Deferred Tax Liability fell to $390.7 million in Q1 2026 per STE's latest filing, from $414.5 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $790.8 million in Q2 2022 and bottomed at $390.7 million in Q1 2026.
- The 5-year median for Non-Current Deferred Tax Liability is $479.7 million (2024), against an average of $550.6 million.
- Across the five-year window, Non-Current Deferred Tax Liability surged 229.57% in 2022 and decreased 27.04% in 2024, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $724.6 million in 2022, then dropped by 14.29% to $621.1 million in 2023, then dropped by 27.04% to $453.1 million in 2024, then retreated by 8.52% to $414.5 million in 2025, then dropped by 5.74% to $390.7 million in 2026.
- Per Business Quant, the three latest STE Non-Current Deferred Tax Liability figures stand at $390.7 million (Q1 2026), $414.5 million (Q4 2025), and $412.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 390.70 Mn |
| Mar 31, 2026 | 390.70 Mn |
| Dec 31, 2025 | 414.50 Mn |
| Dec 31, 2025 | 414.50 Mn |
| Sep 30, 2025 | 412.00 Mn |
| Sep 30, 2025 | 412.00 Mn |
| Jun 30, 2025 | 411.40 Mn |
| Jun 30, 2025 | 411.40 Mn |
| Mar 31, 2025 | 403.70 Mn |
| Mar 31, 2025 | 403.70 Mn |
| Dec 31, 2024 | 453.13 Mn |
| Dec 31, 2024 | 453.13 Mn |
| Sep 30, 2024 | 462.74 Mn |
| Sep 30, 2024 | 462.74 Mn |
| Jun 30, 2024 | 456.47 Mn |
| Jun 30, 2024 | 456.47 Mn |
| Mar 31, 2024 | 479.69 Mn |
| Mar 31, 2024 | 479.69 Mn |
| Dec 31, 2023 | 621.07 Mn |
| Dec 31, 2023 | 621.07 Mn |